Empowered control of drugs's dosage in chronic diseases.

Projektinformationen

INSULCLOCK

ID Finanzhilfevereinbarung: 674505

DOI 10.3030/674505

Abgeschlossenes Projekt

EK-Unterschriftsdatum 8 Mai 2015

Startdatum 1 Juni 2015

Enddatum 31 Oktober 2015

Finanziert unter

• INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)

Gesamtkosten € 71 429,00

EU-Beitrag € 50 000,00

Koordiniert durch

INSULCLOUD
Spain

Ziel

INSULCLOCK addresses the opportunity of providing a new product within the growing market for diabetes care, a very serious and painful disease with an expected global patient pool of 380 million by 2025.
More specifically, INSULCLOCK approaches the insulin pens market which totaled above 8 billion € in 2013, with a 9% CAGR for the next years.

More than 25% of diabetics depend on insulin injections daily, and it is estimated that two-thirds of insulin volume is injected via a modern pen devices. In case treatment fails, there is high risk of complications related to vascular and nerve affection and even death.

The goal of our project is to launch market uptake of INCULCLOCK, an integral solution to really help diabetics and their caregivers in self-managing their disease. Thanks to the unique integration of smart electronic devices and mobile&wearable technologies, we create new demand both from patients already using insulin pens and those not doing so because of reliability issues. Also, around their caregivers, not involved today in business, creating an uncontested market space.

In the current market there are smart/memory insulin pen devices however several reasons make INSULCLOCK really unique:

1. It automatically records all critical information related to insulin in-taking for diabetes treatment.
2. It stores data taking full advantage of possibilities offered by the Cloud and mobile application technologies, assuring security and privacy.
3. It integrates wireless communication.
4. It is universal, reusable and even smaller and lighter than competitors.
5. It fulfils these advantages altogether.

We plan to undertake detailed studies for identifying key action points for the internationalization and growth of the company as well as industrialization process, purposes of Phase 2, for which we estimate a total budget of 1M€ for 12 months. In Phase 3 we will focus in further private investment.

Wissenschaftliches Gebiet

• natural sciences › computer and information sciences › internet › internet of things
• medical and health sciences › clinical medicine › endocrinology › diabetes
• engineering and technology › electrical engineering, electronic engineering, information engineering › information engineering › telecommunications › radio technology › bluetooth
• social sciences › economics and business › business and management › business models

Programm/Programme

• H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT) Main Programme
• H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument

Thema/Themen

• ICT-37-2014-1 - Open Disruptive Innovation Scheme (implemented through the SME instrument)

Aufforderung zur Vorschlagseinreichung

H2020-SMEInst-2014-2015

Andere Projekte für diesen Aufruf anzeigen

Unterauftrag

H2020-SMEINST-1-2014

Finanzierungsplan

SME-1 - SME instrument phase 1

Koordinator

INSULCLOUD

• Netto-EU-Beitrag: € 50 000,00
• Adresse: JULIO PALACIOS, 29 13 Esc.A ; 28029 MADRID ; Spanien
• KMU Die Organisation definierte sich zum Zeitpunkt der Unterzeichnung der Finanzhilfevereinbarung selbst als KMU (Kleine und mittlere Unternehmen). Ja:
  Region
  Comunidad de Madrid › Comunidad de Madrid › Madrid
• Region: Comunidad de Madrid › Comunidad de Madrid › Madrid
• Aktivitätstyp: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Gesamtkosten: € 71 429,00